Diaceutics Plc Stock Buy Hold or Sell Recommendation
| DIUXF Stock | USD 1.37 0.00 0.00% |
Assuming the 90 days horizon and your typical level of risk aversion, our recommendation regarding Diaceutics PLC is 'Hold'. Macroaxis provides Diaceutics PLC buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DIUXF positions.
Check out Diaceutics PLC Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Diaceutics and provide practical buy, sell, or hold advice based on investors' constraints. Diaceutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median.
Diaceutics |
Execute Diaceutics PLC Buy or Sell Advice
The Diaceutics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Diaceutics PLC. Macroaxis does not own or have any residual interests in Diaceutics PLC or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Diaceutics PLC's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Diaceutics PLC Trading Alerts and Improvement Suggestions
| Diaceutics PLC generated a negative expected return over the last 90 days | |
| Diaceutics PLC may become a speculative penny stock | |
| About 47.0% of the company shares are held by company insiders |
Diaceutics PLC Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Diaceutics PLC or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Diaceutics PLC's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Diaceutics pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Diaceutics PLC Volatility Alert
At this time Diaceutics PLC exhibits very low volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Diaceutics PLC's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Diaceutics PLC's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Diaceutics PLC Fundamentals Vs Peers
Comparing Diaceutics PLC's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Diaceutics PLC's direct or indirect competition across all of the common fundamentals between Diaceutics PLC and the related equities. This way, we can detect undervalued stocks with similar characteristics as Diaceutics PLC or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Diaceutics PLC's fundamental indicators could also be used in its relative valuation, which is a method of valuing Diaceutics PLC by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Diaceutics PLC to competition |
| Fundamentals | Diaceutics PLC | Peer Average |
| Return On Equity | 0.0032 | -0.31 |
| Return On Asset | 3.0E-4 | -0.14 |
| Profit Margin | 0.01 % | (1.27) % |
| Operating Margin | 0 % | (5.51) % |
| Current Valuation | 54.7 M | 16.62 B |
| Shares Outstanding | 84.47 M | 571.82 M |
| Shares Owned By Insiders | 46.89 % | 10.09 % |
| Shares Owned By Institutions | 47.72 % | 39.21 % |
| Price To Earning | 112.00 X | 28.72 X |
| Price To Book | 2.07 X | 9.51 X |
| Price To Sales | 6.10 X | 11.42 X |
| Revenue | 13.94 M | 9.43 B |
| Gross Profit | 10.73 M | 27.38 B |
| EBITDA | 2.35 M | 3.9 B |
| Net Income | 561 K | 570.98 M |
| Cash And Equivalents | 19.68 M | 2.7 B |
| Cash Per Share | 0.23 X | 5.01 X |
| Total Debt | 1.56 M | 5.32 B |
| Debt To Equity | 0.04 % | 48.70 % |
| Current Ratio | 11.41 X | 2.16 X |
| Book Value Per Share | 0.49 X | 1.93 K |
| Cash Flow From Operations | 570 K | 971.22 M |
| Earnings Per Share | 0.01 X | 3.12 X |
| Number Of Employees | 133 | 18.84 K |
| Beta | 0.29 | -0.15 |
| Market Capitalization | 94.61 M | 19.03 B |
| Total Asset | 45.01 M | 29.47 B |
| Z Score | 36.0 | 8.72 |
| Net Asset | 45.01 M |
Diaceutics PLC Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Diaceutics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Diaceutics PLC Buy or Sell Advice
When is the right time to buy or sell Diaceutics PLC? Buying financial instruments such as Diaceutics Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Diaceutics PLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Commodities ETFs Thematic Idea Now
Broad Commodities ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Commodities ETFs theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Commodities ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Diaceutics Pink Sheet
Diaceutics PLC financial ratios help investors to determine whether Diaceutics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diaceutics with respect to the benefits of owning Diaceutics PLC security.